Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

I care deeply because this chronic disease is mine. It lives inside me. It’s radically changed my life and the life of my ...

Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, ...

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a ...

DelveInsight’s, “Chronic Kidney Disease Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape.

New UCLA research conducted using mouse models and human genetic data has uncovered a critical factor that determines how much scarring occurs following kidney injury, leading scientists to identify a ...

In March, two biotechnology companies were given the greenlight by the Food and Drug Administration, or FDA, to conduct ...

The company’s porcine liver is for use with partner OrganOx’s extracorporeal liver cross-circulation (ELC) system in patients ...

The FDA has granted a speedy review of Eli Lilly ... to reduce the risk of renal failure and cardiovascular death in people with chronic kidney disease (CKD). The new indication could unlock ...